Association between maternal preventive care utilization and adolescent vaccination: It's not just about pap testing

Journal of Pediatric and Adolescent Gynecology

Volumn 27, Issue 1, 2014, Pages 29-36

  Markovitz, Amanda R ^a   Song, Ji Young ^a   Paustian, Michael L ^a   El Reda, Darline K ^a  

^a Blue Cross Blue Shield of Michigan ^*  (United States)

Author keywords

Adolescents; Cancer screening and prevention; Clinical preventive services; Family; HPV vaccine; Human papillomavirus; Vaccine uptake

Indexed keywords

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AMBULATORY CARE; ARTICLE; CANCER SCREENING; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DAUGHTER; FAMILY CENTERED CARE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MATERNAL ATTITUDE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREDICTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENTS; CANCER SCREENING AND PREVENTION; CLINICAL PREVENTIVE SERVICES; FAMILY; HPV VACCINE; HUMAN PAPILLOMAVIRUS; VACCINE UPTAKE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MOTHERS; NUCLEAR FAMILY; OFFICE VISITS; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE; VAGINAL SMEARS;

EID: 84892487672     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2013.08.012     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention: Genital HPV Infection - Fact Sheet. Available: Accessed August 20, 2012. http://www.cdc.gov/std/HPV/STDFact-HPV.htm.
2. Schiffman M., Castle P.E., Jeronimo J., et al. Human papillomavirus and cervical cancer. Lancet 2007, 370(9590):890.
3. Muñoz N., Bosch F.X., Castellsagué X., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004, 111:278.
4. Lehtinen M., Paavonen J., Wheeler C.M., et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012, 13:89.
5. Wheeler C.M., Castellsague X., Garland S.M., et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012, 13:100.
6. Kjaer S.K., Sigurdsson K., Iversen O.E., et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2009, 2:868.
7. Schiffman M., Wacholder S. Success of HPV vaccination is now a matter of coverage. Lancet Oncol 2012, 13:10.
8. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:671. Centers for Disease Control and Prevention.
9. Kessels S.J., Marshall H.S., Watson M., et al. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012, 30:3546.
10. Laz T.H., Rahman M., Berenson A.B. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012, 30:3534.
11. Kramer M.R., Dunlop A.L. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Matern Child Health J 2012, 16(Suppl 1):S102.
12. The Henry J. Kaiser Family Foundation. Women, Work, and Family Health: A Balancing Act. Available: Accessed September 16, 2012. http://www.kaiserfamilyfoundation.files.wordpress.com/2003/04/3336.pdf.
13. Gerend M.A., Lee S.C., Shepherd J.E. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007, 34:468.
14. Chao C., Slezak J.M., Coleman K.J., et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99:1137.
15. Lefevere E., Hens N., Theeten H., et al. Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine 2011, 29:8390.
16. Monnat S.M., Wallington S.F. Is there an association between maternal pap test use and adolescent human papillomavirus vaccination?. J Adolesc Health 2013, 52:212.
17. Kahn J.A., Rosenthal S.L., Hamann T., et al. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003, 14:300.
18. Rosenthal S.L., Rupp R., Zimet G.D., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008, 43:239.
19. Fazekas K.I., Brewer N.T., Smith J.S. HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt) 2008, 17:539.
20. Reiter P.L., Brewer N.T., Gottlieb S.L., et al. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009, 69:475.
21. Brewer N.T., Gottlieb S.L., Reiter P.L., et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011, 38:197.
22. Williams B., Diehr P., LoGerfo J. Evaluating a preventive services index to adjust for healthy behaviors in observational studies of older adults. Prev Chronic Dis 2010, 7:A110.
23. Corporate Marketing: Blue Cross Blue Shield of Michigan. Detroit, MI.
24. Centers for Disease Control and Prevention: 2011 IISAR Data Participation Rates. Available: Accessed August 1, 2013. http://www.cdc.gov/vaccines/programs/iis/annual-report-IISAR/2011-data.html#adolescent.
25. Goodman D.C., Mick S.S., Bott D., et al. Primary care service areas: a new tool for the evaluation of primary care services. Health Serv Res 2003, 38(1 Pt 1):287.
26. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:626. Centers for Disease Control and Prevention.
27. HEDIS 2011: Healthcare Effectiveness Data and Information Set 2010, National Council for Quality Assurance, National Council for Quality Assurance, Washington, DC.
28. Committee opinion no. 534: well-woman visit. Obstet Gynecol 2012, 120(2 Pt 1):421. Committee on Gynecologic Practice.
29. Starfield B., Shi L., Macinko J. Contribution of primary care to health systems and health. Milbank Q 2005, 83:457.
30. National Council for Quality Assurance: The State of Health Care Quality 2011: Continuous Improvement and the Expansion of Quality Measurement. Available: Accessed February 21, 2013. http://www.ncqa.org/Portals/0/SOHC-web1.pdf.
31. Mechanic D. The influence of mothers on their children's health attitudes and behavior. Pediatrics 1964, 33:444.
32. Wyke S., Hewison J., Russell I.T. Respiratory illness in children: what makes parents decide to consult?. Br J Gen Pract 1990, 40(335):226.
33. Carlos R.C., Dempsey A.F., Resnicow K., et al. Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccination. J Womens Health (Larchmt) 2010, 19:2271.
34. Cox D.S., Cox A.D., Sturm L., et al. Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls. Health Psychol 2010, 29:29.
35. Allen J.D., Coronado G.D., Williams R.S., et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010, 28:4027.
36. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011, 60:1117. Centers for Disease Control and Prevention.
37. Rees-Clayton E., Montgomery J.P., Enger K.S., et al. Trends in Michigan early adolescent immunization: 2006-2008. Am J Public Health 2012, 102:1735.
38. Staras S.A., Vadaparampil S.T., Haderxhanaj L.T., et al. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008. J Adolesc Health 2010, 47:381.
39. LoMurray K., Sander M. Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake. Public Health Rep 2011, 126(Suppl 2):78.
40. United States Census Bureau: Michigan QuickFacts. Available: Accessed September 7, 2012. http://quickfacts.census.gov/qfd/states/26000.html.
41. Lindley M.C., Smith P.J., Rodewald L.E. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep 2011, 126(Suppl 2):124.
42. U.S. Department of Health & Human Services. The Affordable Care Act and Immunization. Available: Accessed September 7, 2012. http://www.healthcare.gov/news/factsheets/2010/09/affordable-care-act-immunization.html.
43. Levy B.R., Myers L.M. Preventive health behaviors influenced by self-perceptions of aging. Prev Med 2004, 39:625.
44. Stockwell M.S., Irigoyen M., Martinez R.A., et al. How parents' negative experiences at immunization visits affect child immunization status in a community in New York City. Public Health Rep 2011, 126(Suppl 2):24.
45. Sara Test F., Caskey R., Rankin K.M. The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children's Health. Matern Child Health J 2013, 17:274.